Trials / Not Yet Recruiting
Not Yet RecruitingNCT06702280
Assessing the Safety of an IGY Supplement on the Gut Microbiome
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Nimble Science Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study is to evaluate whether Muno-IgY is effective in enhancing immune health among adults over a six week period.
Detailed description
The goal of this single-arm interventional trial is to evaluate the safety and effectiveness of Muno-IGY in a sample population of 20 healthy adults over a six week period. The intervention will be compared to a baseline before ingestion of the supplement with both qualitative questionnaires, a daily diary, and microbiome data gathered by the SIMBA and LIMBA capsules.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | IgY supplement | Ingesting the immune supplement over the experimental period |
Timeline
- Start date
- 2025-02-01
- Primary completion
- 2025-10-01
- Completion
- 2025-10-01
- First posted
- 2024-11-22
- Last updated
- 2024-11-22
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT06702280. Inclusion in this directory is not an endorsement.